Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients

NCT03506854 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: ISIS 681257

Sponsor

Akcea Therapeutics

Collaborators

[object Object]